
    
      Assess the ability to maintain the plasma HIV viral load below the threshold needed for
      detection (< 50 copies/mL) at 24 weeks of raltegravir/maraviroc therapy without NRTIs and
      PIs, in patients with virological success and presenting with clinical lipohypertrophy.
    
  